intended for the treatment of IBD, as well six other inflammatory conditions across rheumatology and dermatology. “We are in a time where biosimilars for Crohn’s disease and ulcerative colitis ...
Opens in a new tab or window Maintenance treatment with vedolizumab (Entyvio) appeared to be safe and effective in children with inflammatory bowel disease (IBD), with greater effectiveness in ...
Current treatments for IBD are limited. They don't cure the disease and patients require ongoing treatment. High rates of people don't respond to treatments or lose responsiveness over time, so it's ...